End Stage Renal Disease. End stage renal disease
Conditions
Interventions
Intervention 1: Intervention group: Routine treatments include taking cephalexin 500 mg tablets every 6 hours and daily dressing for 7 days and aspirin, one day after implantation graft, was taken in
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The desire to participate in the study Age over 18 years Need hemodialysis or undergoing hemodialysis Not taking anti-coagulant drugs
Exclusion criteria
Exclusion criteria: Pregnant or lactating women Patients at high risk of bleeding Patients with platelet counts less than 7500 ml Patients with liver disease and other advanced diseases Patients need anticoagulants other than aspirin Patients with dead gastritis before the examination In case of severe complications in the patient due to aspirin use Cerebral hemorrhagic diseases Gastrointestinal bleeding disorders Bleeding diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Graft patency. Timepoint: Monthly for one year. Method of measurement: Decreased blood flow will be assessed by touch or listening, as well as when the dialysis needle is inserted into the graft during hemodialysis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Reza Mannani
Zanjan University of Medical Sciences
Outcome results
None listed